课题基金 / 基金详情

Role of immature myeloid cells in premetastatic lung

Role of immature myeloid cells in premetastatic lung
未成熟骨髓细胞在转移前肺中的作用
批准号:
8157667
负责人:
Li Yang
金额:
$40.45万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
关键词:

项目摘要

项目成果

Li Yang的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have found that Gr-1+CD11b+ cells are significantly increased in lungs of mice bearing mammary adenocarcinomas prior to tumor cell arrival. In the premetastatic lungs, these immature myeloid cells significantly decrease IFN-gamma production and increase pro-inflammatory cytokines. In addition, they produce large quantities of MMP9 and promote vascular remodeling. Deletion of MMP9 normalizes aberrant vasculature in the premetastatic lung, and diminishes lung metastasis. The production and activity of MMP9 is selectively restricted to lungs and organs with a large number of Gr-1+CD11b+ cells. Our work reveals a novel pro-tumor mechanism for Gr-1+CD11b+ cells that changes the premetastatic lung into an inflammatory and proliferative environment, diminishes immune protection and promotes metastasis through aberrant vasculature formation. Thus inhibition of Gr-1+CD11b+ cells could normalize the premetastatic lung environment, improve host immunosurveillance, and inhibit tumor metastasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluate the Role and Mechanism of GPR4 in Immunotherapy-Related Colitis
  • 批准号:
    10580825
  • 项目类别:
  • 资助金额:
    $7.55万
  • 财政年份:
    2022
  • 负责人:
    Li Yang
  • 依托单位:
Evaluate the Role and Mechanism of GPR4 in Immunotherapy-Related Colitis
  • 批准号:
    10437296
  • 项目类别:
  • 资助金额:
    $7.55万
  • 财政年份:
    2022
  • 负责人:
    Li Yang
  • 依托单位:
Dissect the Timing Mechanism for Immune Maturation in Plants
  • 批准号:
    10672250
  • 项目类别:
  • 资助金额:
    $34.92万
  • 财政年份:
    2021
  • 负责人:
    Li Yang
  • 依托单位:
Dissect the Timing Mechanism for Immune Maturation in Plants
  • 批准号:
    10441597
  • 项目类别:
  • 资助金额:
    $34.94万
  • 财政年份:
    2021
  • 负责人:
    Li Yang
  • 依托单位:
国内基金
海外基金
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位: